Howard Marks and Sohn’s big stars reveal seven rules for investing

Among the stock picks and stunts at the Sohh Hearts & Minds event, Howard Marks and Nick Moakes provided investors with long-term rules for playing markets.

James Thomson

Howard Marks and Sohn’s big stars reveal seven rules for investing

November 15, 2024
Among the stock picks and stunts at the Sohh Hearts & Minds event, Howard Marks and Nick Moakes provided investors with long-term rules for playing markets.
Read Transcript

Trust Howard Marks to deliver the line of the day at the Sohn Hearts & Minds Investment Leaders Conference in Adelaide on Friday, which was abuzz with chat about the prospects for investing under the second Donald Trump administration.

‍What will Trump mean for inflation? What will he mean for growth? What will he mean for geopolitics, and particularly China, which Australia is so reliant on?

‍Howard Marks, co-founder of Oaktree Capital, is prepared to give Trump the benefit of the doubt.  Picture: David Rowe

‍Marks, who declared he was willing to give the second Trump administration the benefit of the doubt, was quick to emphasise that he’s no geopolitical expert.

“Which probably means I’m qualified for a cabinet position,” he quipped.

‍Marks warned Trump “will continue to come out swinging in regards to China” but also predicted that both China and Australia could find ways to navigate the great economic rivalry of our time.

‍China, Marks pointed out, still wants to grow its economy by 5 per cent a year, and there’s simply not enough domestic demand or export demand from countries like Russia, Iran and North Korea to deliver on that goal. “They’re going to have to play by most of the rules and remain part of the world economic community,” Marks said.

Howard Marks, billionaire US investor and Oaktree Capital co-founder. Photo: Ben Searcy

The other big star of the day was Nick Moakes, chief investment officer at the £36.8 billion ($72 billion) Wellcome Trust, which gives a staggering £1.7 billion to medical research each year. He offered a different perspective on China and geopolitics. While the growth of its economy over the last few decades has been staggering, it’s been very hard to make money for the simple fact the economy is hugely competitive, and margins in any given sector are quickly competed away.

But it’s not the only reason he’s wary of investing in China. “We have to worry about the return of our capital as much as the return on our capital,” he said.

Moakes thinks hard about geopolitics, but he also delivered a reminder that should stay at the forefront of investors’ minds as the market ties itself in knots in the coming months trying to second-guess Donald Trump’s next move.

“Ultimately what we are buying is assets, not economies.”

Here are seven big lessons from Moakes and Marks, the stars of the Sohn show on Friday.

Rule number one

Moakes doesn’t like the concept of ESG, which he says has been hijacked by the investment management sector for marketing purposes. But governance explains “rule number one” at the Wellcome Trust. “Don’t invest in anything where the people behind it are, have been, or should be, in prison.”

Easy to say, but sadly not always easy to do.

How to think about returns

‍Moakes comes at investing from a different perspective. His fund has no clients and no time frame – his job is to keep earning money that can be given away. Still, the way he thinks about returns is fascinating.

Using 10 years as a proxy time frame for a long-term investment, he considers four things: what’s the reasonable expected return from an investment; what’s the risk of losing all the Trust’s money on a permanent basis; what liquidity is available (recognising Moakes needs more liquidity than other investors because he wants to keep the money flowing to medical research); and what level of control does he have over the asset.

The higher the risk of permanent capital destruction, the lower the level of liquidity on offer, and the less control Moakes has – does he own 100 per cent of the asset or is he just one of many shareholders, as in a public company? – the greater the excess return he will demand. The Trust targets an inflation-adjusted return of about 4 per cent.

Mainly, do nothing

‍Moakes provided a wry lesson about investment frequency. “What I say to my team is: if in doubt, do nothing. And I am usually in doubt.”

Only four or five big decisions in the past 20 years have made a difference to the Wellcome Trust portfolio, and so when a big change of direction or decision does come up, Moakes wants to place a sizeable bet that can actually make a meaningful difference to returns.

Investors, he reminded the 700-strong crowd, are there to take risk.

Cashflow beats everything

‍Local investing legend Peter Cooper, who interviewed Marks on stage with Chanticleer, probed the Wall Street titan about his thoughts on one of the year’s hottest asset classes: gold. Suffice to say, Marks isn’t a fan.

“If an asset produces cash – a company, a building, a stock, a bond, et cetera – you can assign an intrinsic value to it. But it doesn’t produce cash flow – oil, furs, diamonds, art, crypto and may I say, gold – I think you can’t calculate an intrinsic value, and so investing in it approaches what I would call speculation.”

Moakes didn’t comment on gold, but he takes a similar view of the importance of cash flow.

“The single most important thing is that you need to be invested in real assets … that means you want to own equities of any flavour,” he said. That includes everything from public and private equities to venture capital.

It’s still very hard to beat the US

Many of those equities, Moakes says, continue to be found in the US. His view is that innovation equals productivity, which in turn equals outsized returns. “If you’re going to be investing across the spectrum of venture capital, buy-out funds, all the way through to public equities, you’re naturally going to end up going to the US.”

Marks has a similar view. The US has the world’s greatest mix of “free markets, economic dynamism, creativity, rule of law, personal freedoms [and] deep capital markets” and will probably stay that way. But with valuations historically stretched, Marks did remind the audience “you’re not getting that excellence for nothing”.

Look for the G-TOOT

‍Around the offices of the Wellcome Trust, they like to talk about G-TOOTs – the Greatest Trades of our Time.

Moakes has done two of them, he reckons: in 2018 and 2021, the Wellcome Trust issued bonds at extremely low coupon rates (2.57 per cent and 1.50 per cent) for 100 years and 50 years respectively. Moakes estimates the former deal, where the Trust raised £750 million, could create £20 billion of value if it can achieve that targeted real return of 4 per cent over the next century.

We’re not going back

‍Moakes and Marks were in furious agreement about where inflation and interest rates are heading. The idea that rates are heading back towards 2 per cent, Moakes says, is “bullshit, in my view”.

Marks, who says we may actually be done for US interest rate cuts in the short term given the strength of the economy, expects long-term interest rates to hover around the 3 per cent range. “What that means is that investors in what we call credit or debt or fixed income will be able to achieve good, healthy returns from debt, dependably.”

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Trust Howard Marks to deliver the line of the day at the Sohn Hearts & Minds Investment Leaders Conference in Adelaide on Friday, which was abuzz with chat about the prospects for investing under the second Donald Trump administration.

‍What will Trump mean for inflation? What will he mean for growth? What will he mean for geopolitics, and particularly China, which Australia is so reliant on?

‍Howard Marks, co-founder of Oaktree Capital, is prepared to give Trump the benefit of the doubt.  Picture: David Rowe

‍Marks, who declared he was willing to give the second Trump administration the benefit of the doubt, was quick to emphasise that he’s no geopolitical expert.

“Which probably means I’m qualified for a cabinet position,” he quipped.

‍Marks warned Trump “will continue to come out swinging in regards to China” but also predicted that both China and Australia could find ways to navigate the great economic rivalry of our time.

‍China, Marks pointed out, still wants to grow its economy by 5 per cent a year, and there’s simply not enough domestic demand or export demand from countries like Russia, Iran and North Korea to deliver on that goal. “They’re going to have to play by most of the rules and remain part of the world economic community,” Marks said.

Howard Marks, billionaire US investor and Oaktree Capital co-founder. Photo: Ben Searcy

The other big star of the day was Nick Moakes, chief investment officer at the £36.8 billion ($72 billion) Wellcome Trust, which gives a staggering £1.7 billion to medical research each year. He offered a different perspective on China and geopolitics. While the growth of its economy over the last few decades has been staggering, it’s been very hard to make money for the simple fact the economy is hugely competitive, and margins in any given sector are quickly competed away.

But it’s not the only reason he’s wary of investing in China. “We have to worry about the return of our capital as much as the return on our capital,” he said.

Moakes thinks hard about geopolitics, but he also delivered a reminder that should stay at the forefront of investors’ minds as the market ties itself in knots in the coming months trying to second-guess Donald Trump’s next move.

“Ultimately what we are buying is assets, not economies.”

Here are seven big lessons from Moakes and Marks, the stars of the Sohn show on Friday.

Rule number one

Moakes doesn’t like the concept of ESG, which he says has been hijacked by the investment management sector for marketing purposes. But governance explains “rule number one” at the Wellcome Trust. “Don’t invest in anything where the people behind it are, have been, or should be, in prison.”

Easy to say, but sadly not always easy to do.

How to think about returns

‍Moakes comes at investing from a different perspective. His fund has no clients and no time frame – his job is to keep earning money that can be given away. Still, the way he thinks about returns is fascinating.

Using 10 years as a proxy time frame for a long-term investment, he considers four things: what’s the reasonable expected return from an investment; what’s the risk of losing all the Trust’s money on a permanent basis; what liquidity is available (recognising Moakes needs more liquidity than other investors because he wants to keep the money flowing to medical research); and what level of control does he have over the asset.

The higher the risk of permanent capital destruction, the lower the level of liquidity on offer, and the less control Moakes has – does he own 100 per cent of the asset or is he just one of many shareholders, as in a public company? – the greater the excess return he will demand. The Trust targets an inflation-adjusted return of about 4 per cent.

Mainly, do nothing

‍Moakes provided a wry lesson about investment frequency. “What I say to my team is: if in doubt, do nothing. And I am usually in doubt.”

Only four or five big decisions in the past 20 years have made a difference to the Wellcome Trust portfolio, and so when a big change of direction or decision does come up, Moakes wants to place a sizeable bet that can actually make a meaningful difference to returns.

Investors, he reminded the 700-strong crowd, are there to take risk.

Cashflow beats everything

‍Local investing legend Peter Cooper, who interviewed Marks on stage with Chanticleer, probed the Wall Street titan about his thoughts on one of the year’s hottest asset classes: gold. Suffice to say, Marks isn’t a fan.

“If an asset produces cash – a company, a building, a stock, a bond, et cetera – you can assign an intrinsic value to it. But it doesn’t produce cash flow – oil, furs, diamonds, art, crypto and may I say, gold – I think you can’t calculate an intrinsic value, and so investing in it approaches what I would call speculation.”

Moakes didn’t comment on gold, but he takes a similar view of the importance of cash flow.

“The single most important thing is that you need to be invested in real assets … that means you want to own equities of any flavour,” he said. That includes everything from public and private equities to venture capital.

It’s still very hard to beat the US

Many of those equities, Moakes says, continue to be found in the US. His view is that innovation equals productivity, which in turn equals outsized returns. “If you’re going to be investing across the spectrum of venture capital, buy-out funds, all the way through to public equities, you’re naturally going to end up going to the US.”

Marks has a similar view. The US has the world’s greatest mix of “free markets, economic dynamism, creativity, rule of law, personal freedoms [and] deep capital markets” and will probably stay that way. But with valuations historically stretched, Marks did remind the audience “you’re not getting that excellence for nothing”.

Look for the G-TOOT

‍Around the offices of the Wellcome Trust, they like to talk about G-TOOTs – the Greatest Trades of our Time.

Moakes has done two of them, he reckons: in 2018 and 2021, the Wellcome Trust issued bonds at extremely low coupon rates (2.57 per cent and 1.50 per cent) for 100 years and 50 years respectively. Moakes estimates the former deal, where the Trust raised £750 million, could create £20 billion of value if it can achieve that targeted real return of 4 per cent over the next century.

We’re not going back

‍Moakes and Marks were in furious agreement about where inflation and interest rates are heading. The idea that rates are heading back towards 2 per cent, Moakes says, is “bullshit, in my view”.

Marks, who says we may actually be done for US interest rate cuts in the short term given the strength of the economy, expects long-term interest rates to hover around the 3 per cent range. “What that means is that investors in what we call credit or debt or fixed income will be able to achieve good, healthy returns from debt, dependably.”

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by Australian Financial Review, published on Nov 15, 2024. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Ravi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn Licht
October 23, 2023

US Bank Run Has Slowed To A Walk, But Instability Remains

When Ravi Chopra reveals his stock pick at the prestigious Sohn Hearts & Minds conference at the Opera House in Sydney next month, it could well be a short bet on a US bank.

Read More
October 18, 2023

Two small caps: Propel Funeral Services (ASX: PFP) and Clarity Pharmaceuticals (ASX: CU6)

Get to know our 2023 Conference Fund Manager Rikki Bannan of IFM Investors who recently featured on the Equity Mates Media podcast.

Read More
October 16, 2023

How this hedge fund pulled off 2023’s ‘big short’

Last year, Ravi Chopra was travelling through Europe to shop his latest short idea to potential investors. “Financials are really all in the weeds,” he told The Australian Financial Review in an interview from New York.

Read More
IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.
October 10, 2023

Beware the pitfalls of investing in healthcare, says IFM boss

“Healthcare is often viewed as a stable, defensive sector to invest in, but in small caps that hasn’t necessarily proven to be the case,” she says in an interview ahead of her appearance at the Sohn Hearts & Minds Conference 2023.

Read More
October 6, 2023

Secret to a long life cheaper than you think celebrity physician Peter Attia reveals

Don't miss Dr Peter Attia who will speak at the Sohn Hearts & Minds Conference at the Sydney Opera House next month.

Read More
Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.
September 18, 2023

‘Volatility is opportunity’: why this manager loves shorting stocks

Angela Aldrich of Bayberry Capital Partners LP bet against Treasury Wine Estates at the top of the market and now she's preparing to make her next big call at this year's Sohn Hearts & Minds Conference.

Read More
September 15, 2023

Top fund managers share 11 stock picks for the long term

After a dramatic earnings season, fund managers, including Jessica Farr-Jones of Regal Funds and Kieran Moore of Munro Partners (HM1 Core Fund Managers), have shared some of their top picks for long-term growth.

Read More
September 11, 2023

Investors Sweeten On Hedge Funds As Rates Climb

After a decade of easy money pushing equity markets in one direction, Wall Street hedge fund manager Ricky Sandler says the return of volatility and higher interest rates is seeing money return to long-short strategies.

Read More
Eminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John Feder
September 11, 2023

Stock Stars Look Under The Surface

Influential New York-hedge fund manager Ricky Sandler returns to Australia to make a new pick at this year’s Sohn Hearts & Minds conference that will be held at the Sydney Opera House on November 17.

Read More
Barrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter Rae
September 11, 2023

Top Ny Stock Picker Warns Inflation To Remain Above Pre-Covid Levels

Influential New York hedge fund manager Ricky Sandler of Eminence Capital returns for the 2023 Sohn Hearts & Minds Conference in Sydney and says no one is focused on picking interesting, idiosyncratic stocks.

Read More
August 4, 2023

New Relic

New Relic was pitched by Ricky Sandler of Eminence Capital at the 2022 Sohn Hearts & Minds Conference.

Read More
June 18, 2023

Investors can’t agree how to value the world’s hottest stock

Despite mixed investor opinions, Munro Partners (Core Fund Manager) remains a strong believer in Nvidia. They are standing firm in their investment and still consider it a solid buy.

Read More
June 8, 2023

Stock pickers bet the field in slowing domestic market

Fund managers have batted away fears of an inflation-led recession, with Qantas, Seven Group and Treasury Wines named among the best investments by Australia’s top stock pickers.

Read More
March 27, 2023

The imaginary nepotism that drives Carsales global growth

The long-term approach of Carsales (2022 Conference stock pick) and its CEO Cameron McIntyre has delivered big gains for investors. He reveals his secret to staying strategic.

Read More
March 12, 2023

Jun Bei Liu is not giving up on the China reopening theme

Tribeca’s Jun Bei Liu says China’s reopening is only getting started, and names five ASX stocks set to benefit.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.